AbCellera Biologics Inc. (ABCL)
USD 2.69
(-3.58%)
USD 2.69
(-3.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 38.02 Million | 485.42 Million | 375.2 Million | 233.15 Million | 11.61 Million | 8.83 Million |
| Cost of Revenue | - | 66.43 Million | 45.51 Million | 27.14 Million | 10.11 Million | 5.8 Million |
| Gross Profit | 38.02 Million | 418.98 Million | 329.68 Million | 206.01 Million | 1.49 Million | 3.02 Million |
| Operating Expenses | 275.23 Million | 191.92 Million | 107.78 Million | 41.66 Million | 13.95 Million | 7.99 Million |
| Selling, General and Administrative Expenses | 75.17 Million | 66.75 Million | 48.76 Million | 15.75 Million | 4.01 Million | 2.86 Million |
| Research and Development Expenses | 175.65 Million | 107.87 Million | 62.06 Million | 29.39 Million | 10.11 Million | 5.8 Million |
| Other Expenses | 24.39 Million | 17.28 Million | -3.03 Million | -3.48 Million | -170.41 Thousand | -675.5 Thousand |
| Cost and Expenses | 275.23 Million | 258.35 Million | 153.3 Million | 68.8 Million | 13.95 Million | 7.99 Million |
| Operating Income | -237.2 Million | 216.51 Million | 204.41 Million | 156.03 Million | -4.11 Million | -753 Thousand |
| Interest Expense | - | 4.04 Million | 5.22 Million | 6.51 Million | 209.19 Thousand | 212 Thousand |
| Income Tax Expense | -27.63 Million | 80.58 Million | 65.68 Million | 38.91 Million | 209.19 Thousand | 1.27 Million |
| Earnings before Tax | -174.02 Million | 239.09 Million | 219.14 Million | 157.83 Million | -2.21 Million | 309 Thousand |
| Net Income | -146.39 Million | 158.51 Million | 153.46 Million | 118.91 Million | -2.41 Million | 309 Thousand |
| Earnings Per Share Basic | -0.51 | 0.56 | 0.56 | 0.44 | -0.02 | 0.00 |
| Earnings Per Share Diluted | -0.51 | 0.50 | 0.48 | 0.44 | -0.02 | 0.00 |
| Weighted Average Shares Outstanding | 289.16 Million | 285.05 Million | 275.76 Million | 269.49 Million | 154.09 Million | 237.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 289.16 Million | 314.82 Million | 318.29 Million | 269.49 Million | 154.09 Million | 237.72 Million |
| Gross Margin | 1.00 | 0.86 | 0.88 | 0.88 | 0.13 | 0.34 |
| EBIT Margin | -5.05 | 0.57 | 0.65 | 0.73 | -0.03 | 0.20 |
| Profit Margin | -3.85 | 0.33 | 0.41 | 0.51 | -0.21 | 0.03 |
| EBITDA | -192.15 Million | 272.2 Million | 241.62 Million | 169.61 Million | -397.41 Thousand | 165 Thousand |
| Earnings Before Tax Margin | -6.24 | 0.45 | 0.54 | 0.67 | -0.35 | -0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 6.5 Million | 7.32 Million | 9.95 Million | 38.02 Million | 9.17 Million | 6.59 Million |
| Cost of Revenue | 38.29 Million | 38.03 Million | 6.76 Million | 30.89 Million | 9.1 Million | 7.4 Million |
| Gross Profit | -31.78 Million | -30.71 Million | 3.18 Million | 7.13 Million | 70 Thousand | -810 Thousand |
| Operating Expenses | 100.17 Million | 62.74 Million | 58.08 Million | 261.07 Million | 71.85 Million | 58.66 Million |
| Selling, General and Administrative Expenses | 22.28 Million | 21.81 Million | 18.79 Million | - | 19.07 Million | 17.83 Million |
| Research and Development Expenses | 40.96 Million | 40.92 Million | 39.28 Million | - | 48.62 Million | 37.91 Million |
| Other Expenses | 36.91 Million | 32.15 Million | -1.52 Million | 6.77 Million | 3.1 Million | 2.04 Million |
| Cost and Expenses | 100.17 Million | 100.77 Million | 64.84 Million | 261.07 Million | 71.85 Million | 58.66 Million |
| Operating Income | -93.66 Million | -93.45 Million | -54.89 Million | -237.2 Million | -66.05 Million | -54.89 Million |
| Interest Expense | - | - | - | - | 16.72 Million | - |
| Income Tax Expense | -11.52 Million | -11.25 Million | -2.13 Million | -27.63 Million | -1.45 Million | -10.66 Million |
| Earnings before Tax | -62.63 Million | -48.18 Million | -42.74 Million | -174.02 Million | -48.6 Million | -39.27 Million |
| Net Income | -51.1 Million | -36.93 Million | -40.61 Million | -146.39 Million | -47.15 Million | -28.61 Million |
| Earnings Per Share Basic | -0.17 | -0.13 | -0.14 | - | -0.16 | -0.10 |
| Earnings Per Share Diluted | -0.17 | -0.13 | -0.14 | - | -0.16 | -0.10 |
| Weighted Average Shares Outstanding | 294.85 Million | 294.21 Million | 292.72 Million | 289.16 Million | 290.04 Million | 289.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 294.85 Million | 294.21 Million | 292.72 Million | 289.16 Million | 290.04 Million | 289.49 Million |
| Gross Margin | -4.89 | -4.19 | 0.32 | 0.19 | 0.01 | -0.12 |
| EBIT Margin | -3.95 | -7.57 | -4.84 | - | -5.84 | -6.77 |
| Profit Margin | -7.85 | -5.04 | -4.08 | -3.85 | -5.14 | -4.34 |
| EBITDA | -25.71 Million | -55.41 Million | -48.12 Million | - | -53.56 Million | -44.65 Million |
| Earnings Before Tax Margin | -14.39 | -12.76 | -5.51 | -6.24 | -7.20 | -8.32 |
SBRY
8119
600592
088790
MCO
2883